Press Releases

Stocks In Action: Extended Stay America, Inc. (STAY), Intrexon Corporation (XON), Leidos Holdings, Inc. (LDOS)

Managing-Poor-Performance

Extended Stay America, Inc. (STAY) traded within a range of $16.11 to $16.59 after opening the day at $16.5. The company has seen its stock decrease in value by 0% so far this year. The stock was down close to -2.59% on light volume in last trading session and closed at $16.15 per share. After the recent fall, the stock is currently holding -5.44% below its 52 week high of $17.08 and 58.76% above its 12-month low of $10.56. The shares are up by over 19.28% in the last three months, and the RSI indicator value of 53.54 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Extended Stay America, Inc. develops, owns, and operates hotels in the United States and Canada. As of December 31, 2015, the company had 629 hotels with approximately 69,400 consisting of 626 hotels with approximately 68,900 rooms under the Extended Stay America brand; and 3 hotels with 500 rooms under the Extended Stay Canada brand. It serves customers in the mid-priced extended stay segment. Extended Stay America, Inc. was founded in 1995 and is headquartered in Charlotte, North Carolina.

Intrexon Corporation (XON) failed to extend gains with the stock declining -2.78% or $-0.6 to close the day at $21 on light trading volume of 1.18M shares, compared to its three month average trading volume of 1.26M. The Germantown Maryland 20876 based company has been underperforming the biotechnology group over the past 52 weeks, with the stock losing -27.93%, compared to the industry which has advanced 1.57% over the same period. With RSI of 27.64, the stock should still continue to rise and get closer to its one year target estimate of $44.14, making it a hold for now.

Intrexon Corporation operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; RheoSwitch inducible gene switch; Cell Systems Informatics; AttSite Recombinases; Protein Engineering; antibody discovery; LEAP processing; and ActoBiotics platform. It also provides reproductive technologies and other genetic processes to cattle breeders and producers; genetic preservation and cloning technologies; genetically engineered swine for medical and genetic research; biological insect control solutions; technologies for non-browning apple without the use of any flavor altering chemical or antioxidant additives; and commercial aquaculture products. The company serves health, food, energy, environment, and consumer sectors. Intrexon Corporation has collaboration and license agreements with Ares Trading S.A.; ZIOPHARM Oncology, Inc.; Oragenics, Inc.; Fibrocell Science, Inc.; Genopaver, LLC; S & I Ophthalmic, LLC; OvaXon, LLC; Intrexon Energy Partners, LLC; Persea Bio, LLC; Thrive Agrobiotics, Inc.; Intrexon Energy Partners II, LLC; and others. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland.

Leidos Holdings, Inc. (LDOS) dropped $-0.93 to close the day at a new closing price of $48.62, a -1.88% decrease in value from its previous closing price that moved the stock 69.1% above its 52 week low of $37.79. A total of 1.18M shares exchanged hands during the day compared with its three month average trading volume of 1.36M. The stock, which fluctuated between $48.22 and $49.49 during the day, currently situated -7.54% below its 52 week high. The stock is down by -4.48% in the past one month and up by 18.82% over the past three months. With a one year target estimate of $54.11 and RSI of 31.15, the stock still has upside potential, making it a hold for now.

Leidos Holdings, Inc., an applied technology company, delivers solutions and services in the national security, health, and engineering markets in the United States and internationally. The company’s National Security Solutions segment offers solutions and systems for air, land, sea, space, and cyberspace for the U.S. intelligence community, the U.S. department of defense, military services, the U.S. department of homeland security, and government agencies of U.S. allies abroad, as well as to other federal, civilian, and commercial customers in the national security industry. Its solutions offer technology, intelligence systems, command and control, data analytics, cybersecurity, logistics, and intelligence analysis and operations support services to critical missions. The Health and Engineering segment offers electronic health record (EHR) system and behavior health services; implements and optimizes EHR systems at commercial hospitals; and provides life science research and development support services. This segment also offers process industries engineering services and solutions to mid-tier refineries and industrial companies; security products, services, and solutions; power grid engineering services and solutions; federal environmental and engineering services; and transaction and asset valuation services for the power industry. The Corporate and Other segment engages in the real estate management activities. The company was founded in 1969 and is headquartered in Reston, Virginia.

 

Previous ArticleNext Article

Leave a Reply

Your email address will not be published. Required fields are marked *